Literature DB >> 12960618

Slipped capital femoral epiphysis: physeal histologic features before and after fixation.

Vincenzo Guzzanti1, Francesco Falciglia, Carl L Stanitski, Deborah F Stanitski.   

Abstract

Physeal histopathologic changes following slipped capital femoral epiphysis (SCFE) are usually considered permanent. This assumption may not be correct, since radiographic signs of proximal femoral neck growth and remodeling are commonly seen after fixation. This work analyzed the physeal histologic features of chondroepiphyseal biopsies before and after SCFE surgical fixation but before complete physiologic epiphysiodesis. Eighteen patients, nine with unstable and nine with stable SCFE of varying severity, had pretreatment biopsies. Three patients had postfixation biopsies prior to total physiologic proximal femoral epiphysiodesis. Pretreatment biopsies showed varied degrees of histoarchitectural changes ranging from almost normal arrangement to markedly deranged physeal morphology. Postfixation biopsies showed improved physeal organization in a case of moderate unstable SCFE. In one severe unstable case and one severe stable case, nearly normal physeal architecture was seen. Physeal histopathologic changes appear to improve after fixation. Progressive modulation of the recovering physis after fixation helps explain the remodeling and growth changes seen radiographically after chondroepiphyseal fixation.

Entities:  

Mesh:

Year:  2003        PMID: 12960618     DOI: 10.1097/00004694-200309000-00002

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  9 in total

1.  Leptin Elevation as a Risk Factor for Slipped Capital Femoral Epiphysis Independent of Obesity Status.

Authors:  Schuyler J Halverson; Tracy Warhoover; Gregory A Mencio; Steven A Lovejoy; Jeffrey E Martus; Jonathan G Schoenecker
Journal:  J Bone Joint Surg Am       Date:  2017-05-17       Impact factor: 5.284

2.  Slipped capital femoral epiphysis and its association with endocrine, metabolic and chronic diseases: a systematic review of the literature.

Authors:  M Witbreuk; F J van Kemenade; J A van der Sluijs; E P Jansma; J Rotteveel; B J van Royen
Journal:  J Child Orthop       Date:  2013-03-30       Impact factor: 1.548

3.  Slipped capital femoral epiphysis: an ultrastructural study before and after osteosynthesis.

Authors:  Francesco Falciglia; Angelo Gabriele Aulisa; Marco Giordano; Renata Boldrini; Vincenzo Guzzanti
Journal:  Acta Orthop       Date:  2010-06       Impact factor: 3.717

4.  Continued growth after fixation of slipped capital femoral epiphysis.

Authors:  Per Holmdahl; Torsten Backteman; Aina Danielsson; Johan Kärrholm; Jacques Riad
Journal:  J Child Orthop       Date:  2016-11-05       Impact factor: 1.548

5.  Fixation in slipped capital femoral epiphysis avoiding femoral-acetabular impingement.

Authors:  Francesco Falciglia; Angelo G Aulisa; Marco Giordano; Vincenzo Guzzanti
Journal:  J Orthop Surg Res       Date:  2017-10-30       Impact factor: 2.359

6.  Percutaneous pinning after prolonged skeletal traction with the hip in a flexed position for unstable slipped capital femoral epiphysis: A case series of 11 patients.

Authors:  Masaki Matsushita; Kenichi Mishima; Kohji Iwata; Tadashi Hattori; Naoki Ishiguro; Hiroshi Kitoh
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

7.  Histological, histochemical and ultrastructural study of slipped capital femoral epiphysis.

Authors:  I Tresoldi; A Modesti; M Dragoni; V Potenza; E Ippolito
Journal:  J Child Orthop       Date:  2017-04       Impact factor: 1.548

Review 8.  Treatment of stable slipped capital femoral epiphysis: systematic review and exploratory patient level analysis.

Authors:  H Naseem; S Chatterji; K Tsang; M Hakimi; A Chytas; S Alshryda
Journal:  J Orthop Traumatol       Date:  2017-08-22

9.  Leg length discrepancy after in situ fixation with screw for slipped capital femoral epiphysis.

Authors:  Sungmin Kim; Kun-Bo Park; Hyun Woo Kim; Jong Eun Kim; Hoon Park
Journal:  Sci Rep       Date:  2022-02-10       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.